PHIP

	Ocumension Therapeutics - B
	YOU SHOULD READ THE WARNING IN THE DOCUMENT.

► WARNING ► IMPORTANT ► EXPECTED TIMETABLE ► CONTENTS ► SUMMARY ► DEFINITIONS AND ACRONYMS ► GLOSSARY OF TECHNICAL TERMS ► FORWARD-LOOKING STATEMENTS ► RISK FACTORS ► WAIVERS FROM COMPLIANCE WITH THE LISTING RULES AND EXEMPTION FROM THE COMPANIES (WINDING UP AND MISCELLANEOUS PROVISIONS) ORDINANCE ► INFORMATION ABOUT THIS DOCUMENT AND THE [REDACTED] ► DIRECTORS AND PARTIES INVOLVED IN THE [REDACTED] ► CORPORATE INFORMATION ► INDUSTRY OVERVIEW ► REGULATIONS ► HISTORY, RESTRUCTURING AND CORPORATE STRUCTURE ► BUSINESS ► DIRECTORS, SENIOR MANAGEMENT AND ADVISORS ► RELATIONSHIP WITH CONTROLLING SHAREHOLDERS ► SUBSTANTIAL SHAREHOLDERS ► SHARE CAPITAL ► FINANCIAL INFORMATION ► FUTURE PLANS AND USE OF [REDACTED] ► [REDACTED] ► [REDACTED] ► [REDACTED] ► APPENDIX I - ACCOUNTANTS' REPORT ► APPENDIX II - UNAUDITED PRO FORMA FINANCIAL INFORMATION ► APPENDIX III - SUMMARY OF THE CONSTITUTION OF OUR COMPANY AND CAYMAN COMPANIES LAW ► APPENDIX IV - STATUTORY AND GENERAL INFORMATION ► APPENDIX V - DOCUMENTS DELIVERED TO THE REGISTRAR OF COMPANIES AND AVAILABLE FOR INSPECTION